Regulatory submission assembly AI agent: a blueprint for regulatory operations
How a governed regulatory submission assembly AI agent workforce tracks every eCTD component, checks version and format against the authority's rules, and builds a draft dossier, while regulatory affairs keeps ownership of content, responses and the decision to submit.
- Problem
- Version and format defects surface at publishing QC or at the agency, where one can stop the review clock.
- Agent design
- Tracking, verification, assembly and defect pattern agents under regulatory affairs.
- Systems
- RIM content plan, controlled document repository, eCTD publishing and validation.
- Hard limits
- Agents never write content, sign forms, answer the agency or dispatch a sequence.
- Value levers
- Hours moved from chasing to content, fewer validation failures and assembly-caused deficiencies.
- First release
- Tracking and verification for one submission type and authority, then assembly.
How regulatory submission assembly runs today
Every submission is a deadline-driven publishing project. A new application, variation, renewal, annual report or periodic safety report starts from a content plan: each CTD section, the document that fills it, its owner and its approval date. Regulatory operations keeps that plan in the RIM system or, often, in a spreadsheet beside it. Publishers chase authors in CMC, nonclinical, clinical and labeling, pull approved renditions from the repository, check them against the authority's PDF rules, and place them with the right leaf title, lifecycle operation and study tagging. Parallel filings multiply the work, because each region has its own Module 1 and validation criteria.
The failures are rarely about the science. A Module 3 document goes in at last month's version though a newer one was approved yesterday. A study report arrives with unembedded fonts. A Module 2 hyperlink points to a leaf that moved. These defects surface at QC or on the night-before validator run, and some reach the agency, where a technical rejection or deficiency letter stops the clock. Each defect type needs its own agent action and owner, so mapping them comes first.
| Component issue | Typical root cause | What the agent does | Can agents act alone? |
|---|---|---|---|
| Placement and leaf metadata | Wrong CTD section, leaf title or study tagging | Places it by the regional build rules and records the rule | Within the build rules |
| PDF technical non-conformance | Unembedded fonts, missing bookmarks, security settings | Detects it at intake and returns it to the owner with the failing check | Detect and return only |
| Missing or late component | Author behind plan or owner unclear | Chases the owner and escalates with the dispatch impact | Chasing only |
| Broken hyperlink or reference | Target leaf moved or replaced | Resolves links against draft and prior sequences, lists failures | Report, publisher fixes |
| Version conflict | Newer version approved after plan lock, or a draft linked | Shows both versions with lifecycle states and approval dates to the owner | Owner confirms |
| Lifecycle operation on a prior leaf | Unclear if new, replace or append | Proposes the operation with prior sequence history | Publisher confirms |
| Cross-module inconsistency | Module 2 and Module 3 disagree on a specification or batch | Flags the passages side by side to the regulatory lead | Never |
| Module 1 forms, labeling and cover letter | Signed forms, product information, agency commitments | Checks presence and format only; content and signatures stay with owners | Never |
The regulatory submission assembly agent workforce: four roles under regulatory affairs
The live design names tracking, verification and assembly agents; this blueprint adds a fourth that reports where defects come from. Each runs under its own identity. None can change a controlled document, and only the assembly agent writes to the dossier, as a draft. Regulatory affairs owns content, agency responses and the decision to submit.
| Agent | Job | Reads | Can write | Never does |
|---|---|---|---|---|
| Tracking agent | Keeps the content plan current, chases owners and reports readiness against the dispatch date | RIM content plan, milestones, document lifecycle states, owners | Plan item status, reminders and escalations, daily readiness report | Change a due date or owner, or close a missing item |
| Verification agent | Checks each incoming component for current approved version, format conformance and resolved references | Approved renditions, version history, regional build rules, prior sequences | Check result logged against the component, defect notice to the owner | Edit, re-render or substitute a document |
| Assembly agent | Builds the dossier structure and a draft sequence for human review | Verified components, build rules, earlier sequence lifecycle | Draft sequence in the publishing workspace, validation run request, assembly report | Finalize a sequence, sign a form, or transmit through any gateway |
| Defect pattern agent | Reports where defects are born by function, document type and authority | Audit log, QC findings, validation reports, agency feedback | Monthly defect origin report and proposed build rule changes | Act on any open submission |
Submission assembly architecture: agents between RIM, the EDMS and the publishing tool
The agents read the RIM content plan and approved documents through governed API paths, and write only to plan status fields and a draft sequence in your publishing environment. Nothing enters the dossier except from the controlled repository at a recorded version. A control plane outside the agents holds the build rules, human QC, the audit log and a pause switch back to the manual tracker.
How one submission component moves through the checks
Two questions route each component. Does it carry content judgment, a signature or an agency commitment? Then an owner handles it. If not, does it pass every build rule for its slot? Only then is it placed automatically, and the sequence still goes through QC.
RIM, document management and eCTD publishing integration
The pattern holds across vendors: read the plan and approved documents, check against regional rules, write only to a draft sequence. What differs is how each platform exposes its content plan and whether publishing sits in the RIM suite or a separate tool.
| System | What the agents use it for | How agents read | How agents write | Design note |
|---|---|---|---|---|
| RIM (Veeva Vault RIM or another RIM platform) | Content plan, milestones, registrations by market | Platform API for content plan, submission and registration records | Status and comment fields on plan items only | A spreadsheet plan must move into RIM or a governed list first |
| Document repository (Veeva Vault, OpenText Documentum for Life Sciences) | Approved renditions, versions, lifecycle state, owner | API reads of approved or effective documents with version identifiers | None; defect notices go through the repository's tasks | Drafts are never a source; a draft only appears as a version conflict |
| eCTD publishing tool (Vault Submissions Publishing, Lorenz docuBridge, EXTEDO eCTDmanager) | Dossier structure, leaf placement, lifecycle, regional Module 1 | Tool API or import interface, plus earlier sequence backbones | Draft sequence in a working area; the publisher finalizes | Integration depth varies most here; the build starts by testing it |
| eCTD validation (built-in validator or Lorenz eValidator) | Checks drafts against FDA, EMA, Health Canada or other criteria | Validation report per draft sequence | Validation run request on drafts only | High-severity findings block the sequence from QC |
The agents can use the RIM vendor's agent tooling, a hyperscaler AI platform, or a hybrid. Choose on document-system integration and audit-trail quality, since inspectors will review that trail.
Human oversight in regulatory submissions
The risk sits in what the company tells the agency. Agents track, check and place; every decision that changes what the dossier says, or commits the company to it, stays with a named person. Each threshold is a versioned decision owned by the accountable function.
| Decision | Who decides | Agent's role | Control |
|---|---|---|---|
| Owner reminders and escalations | Agent | Chases and escalates | Cadence in the build rules; lead sees escalations |
| Version and format checks | Agent | Runs and logs every check | Rule version logged; QC escapes reviewed monthly |
| Placement of a verified component | Agent | Places it in the draft | Draft only; QC reviews every sequence |
| Lifecycle operation on a submitted leaf | Publisher | Proposes the operation with history | Agent places only after confirmation |
| Version conflict | Document owner | Shows both versions | Held out of the draft until the owner decides |
| Content inconsistency or agency question | Regulatory lead | Flags the passages | No write access to controlled documents |
| Build rule changes | Head of Reg Ops | Proposes changes from the defect report | Versioned; each placement records its version |
| Final sequence approval and dispatch | Submission lead | None | No gateway credentials; out of scope |
Illustrative economics of submission assembly agents
Example inputs are for a group publishing 400 sequences a year across variations, renewals, annual reports and safety reports; replace them with yours. Released hours become cash only if they go to content work. Avoided rework and delay from assembly-caused deficiencies count either way.
Fixed assumptions: components outside agent coverage keep today's effort; build cost includes system validation but not internal team time. Example inputs only. They describe no client and are not a forecast.
With these inputs the case rests on capacity, since avoided deficiencies barely cover running cost. The plan must name where released hours go: authoring support, earlier Module 2 and 3 QC, or a launch wave without new publishers. If a deficiency would delay a new product approval, the cash view changes sharply, so test that input with finance.
Deployment roadmap for submission assembly agents
The live path starts with one submission type and authority, deploys tracking and verification first, adds assembly once the component flow is trusted, then expands authority by authority. The stages add weeks and evidence gates, each signed by the head of regulatory operations.
- Weeks 0 to 4
Baseline
Pick one type for one authority, such as EU variations. Collect recent QC findings and validation reports, measure cycle time and chasing hours, and write the build rules.Gate: head of regulatory operations signs build rules v1 - Weeks 4 to 10
Shadow tracking and checks
Tracking and verification run beside the manual tracker on live submissions. Agent flags are compared with what QC and the validator found.Gate: agents catch 95% of QC-found version and format defects and pass none that QC rejects - Weeks 10 to 18
Controlled assembly
The assembly agent builds draft sequences; publishers confirm lifecycle operations and QC reviews every sequence. The pause switch is tested on a live submission.Gate: three consecutive sequences with no high-severity validation findings and no assembly rework - Week 18 onward
Scale
Add submission types, then authorities, each with its own Module 1 rules and validation criteria. New applications come last.Gate: per submission type, per authority
How submission assembly performance is measured
The live page names four measures: assembly cycle time, defects caught before QC, assembly-caused deficiencies, and chasing against content hours. This blueprint adds a control metric and a leading indicator. All are baselined from your own submissions; none are claimed.
| Metric | Definition | Why it matters |
|---|---|---|
| Assembly cycle time | Days from last component approval to a sequence ready for QC | Time given back to authors before a fixed dispatch date |
| Defects caught before QC | Version and format defects found at intake as a share of all assembly defects | Shows whether defects are being found when they are cheap to fix |
| Escaped defect rate | Defects found by QC or the validator in components agents passed | The control metric; any rise suspends auto-placement for that check |
| Assembly-caused deficiencies | Technical rejections and deficiency letters traced to assembly errors | The outcome that stops the review clock |
| Chasing versus content hours | Hours spent chasing and checking documents against hours on content work | Shows whether released capacity is going where the case assumed |
| First-run validation findings | High and medium findings on the first validation run of each sequence | A leading indicator of dispatch risk |
Questions regulatory operations teams ask about submission assembly agents
Does the agent write or edit submission content?
No. The agents read approved documents and never change them. A defect goes back to the owner, who fixes and re-approves it, and the agent checks the new version.
Can the agent submit to the FDA ESG or the EMA gateway?
No. The agents hold no gateway credentials. Your submission lead approves and dispatches each sequence as today.
Does this replace our publishing tool or our publishing vendor?
Neither. The assembly agent works inside your publishing environment and the publisher finalizes. With outsourced publishing, tracking and verification send the vendor checked components.
How does it handle eCTD 4.0 and regional differences?
Each authority gets its own versioned build rules for Module 1, file rules, lifecycle and validation. A move to eCTD 4.0 is a new rule set, tested in shadow first.
Is this a validated computerized system?
Treat it like your other submission tooling under your computerized system validation approach, focused on the build rules, the audit trail and the boundary that keeps agents out of controlled content.
Working with WGA on regulatory submission assembly
The engagement follows WGA's AI Workforce Solution method and opens with a readiness assessment of data, process and change capacity: where the content plan really lives, how clean the repository's lifecycle states are, and how much of the publishing tool an API can reach. WGA then analyzes QC findings and validation reports from recent sequences to show which defect types the agents should take on and which belong upstream with authors. The build rules are written with your publishing lead, and targets come from your own baseline.
The first release covers one submission type and one authority so value shows quickly. Senior WGA consultants lead the work with fees fixed against the outcome tied to agreed outcomes, and your regulatory operations and IT teams inherit the build rules, validation documents, runbooks and pause procedure, with training to run the agents themselves.
Discuss regulatory submission assembly in your operation
Talk to our AI practice